Trending Now
Community Spotlights

Community Spotlight: Cristina Soler, Co-Founder and CEO, Ramco Litigation Funding

Cristina Soler is CEO and co-founder of Ramco Litigation Funding, a pioneering litigation and arbitration funding firm in Spain with a solid track record. Ramco was founded in the UK in 2015 and in Spain in 2017.

Cristina is a Spanish lawyer with expertise in high-value international litigation and arbitration and has more than 20 years of professional experience in defending and advising on commercial disputes and complex litigation and arbitration matters.  She has worked in leading international law firms advising domestic and foreign clients from different industry sectors, including oil and gas, construction and infrastructure.

Cristina founded Ramco in Spain and has pioneered the introduction of litigation and arbitration finance in Spain since 2017 and has been involved in the financing of some of the most relevant litigation and arbitration cases followed in Spain and other jurisdictions.

Cristina was part of the Advisory Subcommittee for the drafting of the Code of Good Practice (2019) of the Spanish Arbitration Club (CEA). 

Cristina has coordinated the book published by Aranzadi la Ley in 2024 “La Financiación de Litigios en derecho español y comparado” launched by Ramco Litigation Funding  in collaboration with the ICADE University which is the first collective work about Third Party Funding in Spain. She has also authored a Chapter of the book about the Third Party Funding Market in Spain.

Cristina has also co-authored several articles on Third Party Funding, including the Spanish chapter of the 6th and 7th edition of the reference guide on Litigation Funding and Arbitration “In-Depth: Third Party Litigation Funding” (formerly “The Third-Party Litigation Funding Law Review”).

Cristina has recently been recognised in the prestigious worldwide list “Lawdragon Guide” as one of the Global 100 Leaders in the world of litigation finance “Lawdragon Guide’s 100 Global Leaders in Litigation Finance 2022, 2023 and 2024“, being the only Spanish firm to be recognised among the international firms included in the ranking for 3 consecutive years.

Company Description: Ramco is a specialist provider of litigation finance solutions with a strong track record, managed by Spanish litigator Cristina Soler and backed by institutional investors. 

Ramco focuses its activities on high value-added areas such as natural resources and energy, regulatory markets, banking and financial markets, renewable energy, capital projects and infrastructure, competition and antitrust and intellectual property. The team brings together many years of experience in the energy, litigation and finance sectors and has the knowledge and expertise to properly evaluate litigation and arbitration claims. 

Ramco helps leading companies and law firms to optimise their legal assets and provides litigation financing in all its forms, including single case and class action litigation, as well as the financing of arbitrations and the purchase of claims, judgments and awards. Founded in 2017, RAMCO has been involved in the funding of claims with a total value in excess of USD 5 billion, including some of the landmark cases pursued in Spain and other jurisdictions. 

Ramco has been a pioneer in Spain in tailoring the mechanism of litigation funding to the needs and characteristics of the Spanish market due to its knowledge of both the market and the Spanish legal system.

Company Website: www.ramcolf.com

Year Founded:  2017

Headquarters:  Barcelona

Area of Focus: Ramco focuses its activities on high value-added areas such as natural resources and energy, regulatory markets, banking and financial markets, renewable energy, capital projects and infrastructure, international arbitration, competition and antitrust and intellectual property.

Member Quotes:

“Third-party funding allows, apart from financing the costs of the claim, to have a highly qualified team of experts who provide added value to the company’s position in the litigation.”

Cristina Soler, CEO de Ramco Litigation Funding
La Vanguardia, “Ramco or How to Litigate Without Money or Without Risk”

“Spain is an emerging market for litigation funding and litigation and arbitration proceedings arise in sectors of high interest to investors, such as renewables, competition law or banking, among others.”

Cristina Soler, CEO de Ramco Litigation Funding
Expansión, “Litigation Funds Become Strong in Spain”

“Litigation funding wasinitiallyconsolidated in sectors where litigation isparticularly costly,due to theneed forprofessional technical specialization andthe specialeconomic relevanceof the debate andclaimsat stake.”

Cristina Soler, Managing Partner of Ramco LitigationFunding
lberian Lawyer, “Fund Me if You Dare”

Commercial

View All
Commercial Deals

LitFin Launches Initiative in France Supporting Women over Essure Implant Complications

By Harry Moran |

When it comes to medical and personal injury group claims, the financial resources that litigation funders provide is often a vital component of their potential success. However, a new initiative tackling a specific medical claim in France also demonstrates the importance of funders working with specialist law firms and local associations who have the requisite knowledge and experience to support these patients.

In a post on LinkedIn, litigation funder LitFin announced the launch of an initiative to support women in France who have suffered or are suffering health complications related to the Essure contraceptive implant. 

The Essure implant is a non-surgical, permanent method of contraception which was introduced in 2001, but in the years following its use has seen thousands of women develop serious health complications from the implant. Bayer, the manufacturer of Essure, stopped the sale and distribution of the device in 2018.

The initiative launched by LitFin is in collaboration with RESIST, an independent French association founded in 2016 that has been campaigning for and supporting women who have been affected by issues following the use of the implant. Legal support for the initiative is being provided by JVL & Associés, a French law firm located in Rouen, Normandy, that specialises in health law and has 20 years of experience in medical accident claims and patient law.

More information about the initiative and upcoming public events hosted by RESIST can be found on the Implant Compensation Claim website.

Commercial Deals

Litigation Lending Services Funding Queensland Health Class Action

By Harry Moran |

When it comes to the important role that legal funding can play in providing access to justice, some of the most important cases are those that seek to offer that justice to communities who have been the subject of discrimination based on their identity.

In a post on LinkedIn, Litigation Lending Services (LLS) announced that it is funding a class action filed by JGA Saddler and brought on behalf of Aboriginal and Torres Strait Islander peoples against the State of Queensland. The group action focuses on allegations that these communities were subject to racial discrimination by the state in its failure to provide adequate healthcare across Far North and Northwest Queensland.

The representative proceeding, which has been filed with the Federal Court of Australia, represents those people from these communities who were serviced by the North West Hospital and Health Service (NWHHS) and the Torres and Cape Hospital and Health Service (TCHHS). It alleges that between 1996 and 2024, the state breached the Racial Discrimination Act 1975 by preventing these communities from accessing healthcare services “in a manner consistent with their human rights and fundamental freedoms.”

LLS said that it is “committed to supporting access to justice for communities whose voices are too often overlooked.” In a separate post on LinkedIn, Ella Colantonio, chief investment officer at LLS, said that the class action is “a stark reminder of the role litigation can play in challenging systemic inequality and giving voice to communities that have long gone unheard.”

More information about the Queensland Health Class Action can be found on the claim’s website.

Case Developments Commercial

CAT Releases Judgment Approving £200m Settlement in Mastercard Class Action

By Harry Moran |

As LFJ covered in February, a settlement in one of the largest group actions in UK history remains one of the most significant events for legal funding in 2025. With arbitration between the litigation funder and class representation still ongoing, the formal approval of the settlement will stand as a landmark moment  in the Mastercard proceedings, even if the final chapter on the case is yet to be written.

The Competition Appeal Tribunal (CAT) has today released the judgment granting the collective settlement approval order (CSAO) for the £200 million settlement in the Merricks v Mastercard class action. The approval of the settlement signifies the conclusion of proceedings that have dominated headlines both for the size of the claim at stake, and the fallout that followed from a dispute between litigation funder Innsworth and Mr Merricks as the class representative over the size of settlement.

The summary of the judgment released by the CAT detailed the division of the £200 million settlement, with the total amount “split into three pots”. 

Pot 1 represents half of the total settlement at £100 million and is ringfenced for class members, with Merricks enlisting the support of claims administrator Epiq Class Action & Claims Solutions for distribution to class members following a six month notice period. Depending on the volume of class members who come forward with a claim, the individual payout to class members will vary, with £45 per member if there is a 5% uptake. There is also a maximum cap of £70 per member “to prevent excessive individual recovery”.

The Pot 2 total of £45,567,946.28 has been ringfenced for litigation funder Innsworth to account to cover its costs and act as the basis for a minimum return for its investment. 

As the CAT’s judgment awarded Innsworth a 1.5 return on its investment, Pot 3 has a dual purpose. This remaining sum of £54,432,053.72 is set aside to fulfil the remaining profit return to Innsworth, and to supplement Pot 1 should more than 5% of class members submit claims. The judgment also requires any leftover amount in Pot 3 should be paid to “a consumer charity or the Access to Justice Foundation so that more than half of the Settlement Sum is distributed to the Class.” 

Whilst the judgment does not put an end to the arbitration that Innsworth has commenced against Mr Merricks over the settlement, it does approve an indemnity of £10 million that Mastercard has given to Mr Merricks as part of the settlement. The CAT stated this personal indemnity “did not impugn the Tribunal’s view of the settlement.”

The full judgment from the CAT in Walter Hugh Merricks CBE v Mastercard Incorporated and Others can be read here.